Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence.

ABSTRACT: Since Banting and Best isolated insulin in the 1920s, dramatic progress has been made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely injection to maintain optimal glycemic control are often challenging for T1DM patients and their families because they require frequent blood glucose checks. In recent years, technological advances in insulin pumps and continuous glucose monitoring systems have created paradigm shifts in T1DM care that are being extended to develop artificial pancreas systems (APSs). Numerous studies that demonstrate the superiority of glycemic control offered by APSs over those offered by conventional treatment are still being published, and rapid commercialization and use in actual practice have already begun. Given this rapid develo

SUBMITTER: Moon SJ 

PROVIDER: S-EPMC8640161 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature